Free Trial
NASDAQ:ADXN

Addex Therapeutics (ADXN) Stock Price, News & Analysis

Addex Therapeutics logo
$9.29 -0.19 (-2.00%)
As of 07/9/2025 03:54 PM Eastern

About Addex Therapeutics Stock (NASDAQ:ADXN)

Key Stats

Today's Range
$8.91
$9.44
50-Day Range
$7.75
$10.23
52-Week Range
$6.51
$13.27
Volume
5,294 shs
Average Volume
95,009 shs
Market Capitalization
$9.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Consensus Rating
Buy

Company Overview

Addex Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

ADXN MarketRank™: 

Addex Therapeutics scored higher than 57% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Addex Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Addex Therapeutics has received no research coverage in the past 90 days.

  • Read more about Addex Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Addex Therapeutics is -27.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Addex Therapeutics is -27.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Addex Therapeutics has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Addex Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    0.27% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Addex Therapeutics has recently decreased by 4.35%, indicating that investor sentiment is improving.
  • Dividend Yield

    Addex Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Addex Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.27% of the float of Addex Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Addex Therapeutics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Addex Therapeutics has recently decreased by 4.35%, indicating that investor sentiment is improving.
  • News Sentiment

    Addex Therapeutics has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, Addex Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.00% of the stock of Addex Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 16.14% of the stock of Addex Therapeutics is held by institutions.

  • Read more about Addex Therapeutics' insider trading history.
Receive ADXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ADXN Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
See More Headlines

ADXN Stock Analysis - Frequently Asked Questions

Addex Therapeutics' stock was trading at $7.00 on January 1st, 2025. Since then, ADXN shares have increased by 32.7% and is now trading at $9.29.

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) posted its quarterly earnings data on Friday, November, 22nd. The company reported ($2.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.40) by $1.37. Addex Therapeutics had a negative trailing twelve-month return on equity of 54.27% and a net margin of 3,584.49%.
Read the conference call transcript
.

Addex Therapeutics's stock reverse split before market open on Monday, October 23rd 2023.The 1-20 reverse split was announced on Monday, October 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ADXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Addex Therapeutics investors own include Arista Networks (ANET), Adobe (ADBE), NVIDIA (NVDA), Broadcom (AVGO), GE Aerospace (GE), Vista Energy (VIST) and Arch Capital Group (ACGL).

Company Calendar

Last Earnings
11/22/2024
Today
7/09/2025
Next Earnings (Estimated)
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXN
CIK
1574232
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$30.00
Potential Upside/Downside
+222.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.02 million
Net Margins
3,584.49%
Pretax Margin
-2,307.03%

Debt

Sales & Book Value

Annual Sales
$460 thousand
Price / Cash Flow
N/A
Book Value
$10.37 per share
Price / Book
0.90

Miscellaneous

Free Float
901,000
Market Cap
$9.85 million
Optionable
Not Optionable
Beta
1.65
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ADXN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners